Amgen
A Specialist Manufacturing (NPI, Upstream Process Owner) at Amgen supports the introduction of new biologics drug substance products into a state-of-the-art FleX Batch manufacturing facility and serves as the liaison between manufacturing and process development. The role centers on upstream process ownership during new product introduction and ongoing technical stewardship within the biologics manufacturing site.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Upstream NPI Receiving Unit Lead (AD)
MSD
TSMS- Scientist, Upstream
Eli Lilly and Company
Associate Scientific Fellow, Upstream Technology Transfer Lead, Drug Substance Operations, Biotherapeutics Process Development, Pharmaceutical Sciences
BioLife Plasma Services
Associate Director, Drug Substance Manufacturing – Upstream Process
Vera Therapeutics, Inc.
Manager, Process Operations
Merck & Co., Inc.
Manager, Process Operations
MSD